StockData
Prelude Therapeutics Inc logo

Prelude Therapeutics Inc (PRLD) stock

PRLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3055% above fair value
$3.32−0.09 (-2.64%)

Close on Nov 17, 2026Market cap $264.95MP/E –Yield –

Prelude Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Prelude Therapeutics's market cap was $318.23M on Nov 11, 2026, against $127.67M a year earlier. Over the last 5 years it ranged from $57.54M to $471.45M, with a median of $232.66M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$318.23M+44.4%
2025Dec 31, 2025$220.39M+132.8%
2024Dec 31, 2024$94.65M-59.6%
2023Dec 29, 2023$234.11M-17.7%
2022Dec 30, 2022$284.59M+96.2%
2021Jan 29, 2021$145.04M-9.2%
2020Dec 31, 2020$159.77M–

More Prelude Therapeutics figures

See a number that looks wrong?